Original Article

A Cross-Sectional Study of HIV and Tuberculosis Coinfection Cases in Mainland China

Authors: Jiang Xueyan, MD, Lu Hongzhou, MD, Zhang Yuexin, MD, Zhou Zengquan, MD, Ye Hanhui, MD, Zhao Qingxia, MD, Wang Hui, MD, Wang Fuxiang, MD, Jia Wangqian, MD, Sun Hongqing, MD, Ding Limin, MD, Su Yan, MD, He Yun, MD, Maimaitiaili Wubuer, MD, Yibaguli Aibaidoula, MD, Sun Xiaofeng, MD, Hu Yadong, MD, Tang Wei, MD, Zhou Boping, MD, Yunzhen Cao, MD

Abstract

Background: The prevalence of HIV/AIDS and tuberculosis (TB) within mainland China is unprecedented and the convergence of these two infectious diseases is increasingly and significantly endangering human health for socioeconomic development. To date, the clinical manifestations, laboratory presentation, and epidemiologic features of HIV/TB coinfection cases in mainland China have not been described in detail. To assess the incidence, clinical characteristics and outcome of coinfection with HIV and TB, we conducted a cross-sectional study of coinfected cases reported from nine domestic hospitals throughout mainland China.


Method: During the 3-year survey period from January 2003 to December 2005, all patients were followed regularly. Medical records were reviewed, a standardized questionnaire was administered, and clinical databases were analyzed.


Results: A total of 241 cases (183 male, 58 female) with pulmonary TB, extrapulmonary TB, or both, accounted for 9.5%, 21.6%, and 18.7% of cases, respectively. Among the 241 reported cases of HIV/TB coinfection, 76.8% had CD4 cell counts 200/mm3 and 58.5% were 100/mm3. Treatments for TB and HIV were provided to patients and mortality attributable to coinfection was reported for 15.8% of the cases.


Conclusions: The clinical characteristics of HIV/TB coinfection varied among the 241 cases studied with pulmonary TB predominating. Immune function among most patients was suppressed based on reduced CD4+ T cell counts. HIV/TB coinfection was related to high mortality even when HAART and/or drug therapy for TB was provided. Additional sensitive techniques are needed to improve the diagnosis of HIV/TB coinfection.


Key Points


* The characteristics of HIV/TB coinfection in China, including clinical manifestations, laboratory presentation, treatment and prognosis, and epidemiologic features are presented.


* The clinical characteristics of HIV/TB coinfection varied among the patients with pulmonary TB predominating.


* The positive rate of microbiologic diagnosis was lower, so additional sensitive techniques are needed to improve the diagnosis of HIV/TB coinfection.


* HIV/TB coinfection was related to high mortality even when HAART and/or drug therapy for TB was provided, so significant challenges remain with finding therapeutic techniques.

This content is limited to qualifying members.

Existing members, please login first

If you have an existing account please login now to access this article or view purchase options.

Purchase only this article ($25)

Create a free account, then purchase this article to download or access it online for 24 hours.

Purchase an SMJ online subscription ($75)

Create a free account, then purchase a subscription to get complete access to all articles for a full year.

Purchase a membership plan (fees vary)

Premium members can access all articles plus recieve many more benefits. View all membership plans and benefit packages.

References

1.The Epidemic Situation of AIDS and the Advances in its Prevention and Treatment in China in 2005. The Ministry of Health of P. R. China. The Joint United Nations Programme on HIV and AIDS, WHO, 2006.
 
2.Cao Y. HIV-TB co-infection. World J Infect 2006;2:102–105.
 
3.Sharma SK, Mohan A, Kadhiravan T. HIV-TB co-infection: epidemiology, diagnosis and management. Indian J Med Res 2005;121:550–567.
 
4.Liberato IR, de Albuquerque MDEF, Campelo AR, et al. Characteristics of pulmonary tuberculosis in HIV seropositive and seronegative patients in a Northeastern region of Brazil. Rev Soc Bras Med Trop 2004;37: 46–50.
 
5.FitzGerald JM, Houston S. Tuberculosis: 8. The disease in association with HIV infection. CMAJ 1999;161:47–51.
 
6.Aronson NE, Santosham M, Comstock GW, et al. Long-term efficacy of BCG vaccine in American Indians and Alaska Natives. A 60-year follow-up study. JAMA 2004;291:2086–2091.
 
7.Centers for Disease Control and Prevention (CDC). Screening HIV-Infected Persons for Tuberculosis—Cambodia, January 2004–February 2005. MMWR Morb Mortal Wkly Rep 2005;54:1177–1180.
 
8. McShane H. Co-infection with HIV and TB: double trouble. Int J STD AIDS 2005;16:95–100.
 
9. Centers for Disease Control and Prevention (CDC). Acquired rifamycin resistance in persons with advanced HIV disease being treated for active tuberculosis with intermittent rifamycin-based regimens. MMWR Morb Mortal Wkly Rep 2002;51:214–215.